Search This Blog

Monday, May 18, 2026

Boston Scientific to invest $1.5B for 34% of MiRus

 

Boston Scientific to invest $1.5B for 34% of MiRus, secure SIEGEL TAVR option, and launch $2B accelerated share repurchase

  • Accelerated share repurchase is with JPMorgan and expected to add $0.02 to 2026 adjusted EPS guidance.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.